These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A Hexasaccharide Containing Rare 2-O-Sulfate-Glucuronic Acid Residues Selectively Activates Heparin Cofactor II. Sankarayanarayanan NV; Strebel TR; Boothello RS; Sheerin K; Raghuraman A; Sallas F; Mosier PD; Watermeyer ND; Oscarson S; Desai UR Angew Chem Int Ed Engl; 2017 Feb; 56(9):2312-2317. PubMed ID: 28124818 [TBL] [Abstract][Full Text] [Related]
3. 3-O-sulfated oligosaccharide structures are recognized by anti-heparan sulfate antibody HS4C3. Ten Dam GB; Kurup S; van de Westerlo EM; Versteeg EM; Lindahl U; Spillmann D; van Kuppevelt TH J Biol Chem; 2006 Feb; 281(8):4654-62. PubMed ID: 16373349 [TBL] [Abstract][Full Text] [Related]
4. Platelet factor 4 neutralizes heparan sulfate-enhanced antithrombin inactivation of factor Xa by preventing interaction(s) of enzyme with polysaccharide. Fiore MM; Kakkar VV Biochem Biophys Res Commun; 2003 Nov; 311(1):71-6. PubMed ID: 14575696 [TBL] [Abstract][Full Text] [Related]
5. A non-hemorrhagic hybrid heparin/heparan sulfate with anticoagulant potential. Brito AS; Cavalcante RS; Palhares LC; Hughes AJ; Andrade GP; Yates EA; Nader HB; Lima MA; Chavante SF Carbohydr Polym; 2014 Jan; 99():372-8. PubMed ID: 24274520 [TBL] [Abstract][Full Text] [Related]
6. Serpin-independent anticoagulant activity of a fucosylated chondroitin sulfate. Glauser BF; Pereira MS; Monteiro RQ; Mourão PA Thromb Haemost; 2008 Sep; 100(3):420-8. PubMed ID: 18766257 [TBL] [Abstract][Full Text] [Related]
7. The 3- Chopra P; Joshi A; Wu J; Lu W; Yadavalli T; Wolfert MA; Shukla D; Zaia J; Boons GJ Proc Natl Acad Sci U S A; 2021 Jan; 118(3):. PubMed ID: 33441484 [TBL] [Abstract][Full Text] [Related]
8. Mechanisms for the anticoagulant effect of heparin and related polysaccharides. Ofosu FA Nouv Rev Fr Hematol (1978); 1988; 30(3):155-60. PubMed ID: 2971155 [TBL] [Abstract][Full Text] [Related]
9. On the specificity of heparin/heparan sulfate binding to proteins. Anion-binding sites on antithrombin and thrombin are fundamentally different. Mosier PD; Krishnasamy C; Kellogg GE; Desai UR PLoS One; 2012; 7(11):e48632. PubMed ID: 23152789 [TBL] [Abstract][Full Text] [Related]
10. An unusual antithrombin-binding heparin octasaccharide with an additional 3-O-sulfated glucosamine in the active pentasaccharide sequence. Guerrini M; Elli S; Mourier P; Rudd TR; Gaudesi D; Casu B; Boudier C; Torri G; Viskov C Biochem J; 2013 Jan; 449(2):343-51. PubMed ID: 23083208 [TBL] [Abstract][Full Text] [Related]
11. Antithrombin conformational modulation by D-myo-inositol 3,4,5,6-tetrakisphosphate (TMI), a novel scaffold for the development of antithrombotic agents. Arantes PR; Pérez-Sánchez H; Verli H J Biomol Struct Dyn; 2018 Nov; 36(15):4045-4056. PubMed ID: 29173042 [TBL] [Abstract][Full Text] [Related]
12. (1)H nuclear magnetic resonance spectroscopic analysis for determination of glucuronic and iduronic acids in dermatan sulfate, heparin, and heparan sulfate. Sudo M; Sato K; Chaidedgumjorn A; Toyoda H; Toida T; Imanari T Anal Biochem; 2001 Oct; 297(1):42-51. PubMed ID: 11567526 [TBL] [Abstract][Full Text] [Related]
13. Finding a needle in a haystack: development of a combinatorial virtual screening approach for identifying high specificity heparin/heparan sulfate sequence(s). Raghuraman A; Mosier PD; Desai UR J Med Chem; 2006 Jun; 49(12):3553-62. PubMed ID: 16759098 [TBL] [Abstract][Full Text] [Related]
14. Heparin cofactor II is degraded by heparan sulfate and dextran sulfate. Saito A Biochem Biophys Res Commun; 2015 Feb; 457(4):585-8. PubMed ID: 25600805 [TBL] [Abstract][Full Text] [Related]
15. Antithrombin activation by nonsulfated, non-polysaccharide organic polymer. Monien BH; Desai UR J Med Chem; 2005 Feb; 48(4):1269-73. PubMed ID: 15715496 [TBL] [Abstract][Full Text] [Related]
16. Relative susceptibilities of the glucosamine-glucuronic acid and N-acetylglucosamine-glucuronic acid linkages to heparin lyase III. Chai W; Leteux C; Westling C; Lindahl U; Feizi T Biochemistry; 2004 Jul; 43(26):8590-9. PubMed ID: 15222770 [TBL] [Abstract][Full Text] [Related]
17. Biosynthesis of 3-O-sulfated heparan sulfate: unique substrate specificity of heparan sulfate 3-O-sulfotransferase isoform 5. Chen J; Duncan MB; Carrick K; Pope RM; Liu J Glycobiology; 2003 Nov; 13(11):785-94. PubMed ID: 12907690 [TBL] [Abstract][Full Text] [Related]
18. The ternary complex of antithrombin-anhydrothrombin-heparin reveals the basis of inhibitor specificity. Dementiev A; Petitou M; Herbert JM; Gettins PG Nat Struct Mol Biol; 2004 Sep; 11(9):863-7. PubMed ID: 15311268 [TBL] [Abstract][Full Text] [Related]
19. Osmotic stress regulates the anticoagulant efficiency of dermatan sulfate. McGee MP; Wagner W; Li L Matrix Biol; 2004 Oct; 23(6):363-70. PubMed ID: 15533757 [TBL] [Abstract][Full Text] [Related]
20. Sulfamate proton solvent exchange in heparin oligosaccharides: evidence for a persistent hydrogen bond in the antithrombin-binding pentasaccharide Arixtra. Langeslay DJ; Young RP; Beni S; Beecher CN; Mueller LJ; Larive CK Glycobiology; 2012 Sep; 22(9):1173-82. PubMed ID: 22593556 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]